164 related articles for article (PubMed ID: 27509928)
1. Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies.
Majeed W; Iftikhar A; Khaliq T; Aslam B; Muzaffar H; Atta K; Mahmood A; Waris S
Asian Pac J Cancer Prev; 2016; 17(7):3053-60. PubMed ID: 27509928
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy in advanced gastric carcinoma: the future is beginning.
Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
[TBL] [Abstract][Full Text] [Related]
3. Predictive biomarkers along gastric cancer pathogenetic pathways.
Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R
Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834
[TBL] [Abstract][Full Text] [Related]
4. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
[TBL] [Abstract][Full Text] [Related]
5. BRUCE Protein, New Marker for Targeted Therapy of Gastric Carcinoma.
Salehi S; Jafarian AH; Montazer M; Moghbeli M; Forghanifard MM
J Gastrointest Cancer; 2017 Jun; 48(2):151-155. PubMed ID: 27614745
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.
Yashiro M; Matsuoka T
World J Gastroenterol; 2016 Feb; 22(8):2415-23. PubMed ID: 26937130
[TBL] [Abstract][Full Text] [Related]
7. [New therapies in thyroid cancer].
López Mondéjar P; Galofré JC
Med Clin (Barc); 2016 Apr; 146(7):324-9. PubMed ID: 26723936
[No Abstract] [Full Text] [Related]
8. Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Dahle-Smith A; Petty RD
Expert Rev Anticancer Ther; 2015; 15(9):1103-19. PubMed ID: 26313419
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism in gastric cancer: The cutting-edge.
Yuan LW; Yamashita H; Seto Y
World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeted therapy for the treatment of gastric cancer.
Xu W; Yang Z; Lu N
J Exp Clin Cancer Res; 2016 Jan; 35():1. PubMed ID: 26728266
[TBL] [Abstract][Full Text] [Related]
11. Current and future biomarkers in gastric cancer.
Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 and gastric cancer.
Thiel A; Mrena J; Ristimäki A
Cancer Metastasis Rev; 2011 Dec; 30(3-4):387-95. PubMed ID: 22002749
[TBL] [Abstract][Full Text] [Related]
13. Molecular in vivo imaging of gastric cancer in a human-murine xenograft model: targeting epidermal growth factor receptor.
Hoetker MS; Kiesslich R; Diken M; Moehler M; Galle PR; Li Y; Goetz M
Gastrointest Endosc; 2012 Sep; 76(3):612-20. PubMed ID: 22771099
[TBL] [Abstract][Full Text] [Related]
14. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
15. The application of nanoparticles in diagnosis and theranostics of gastric cancer.
Li R; Liu B; Gao J
Cancer Lett; 2017 Feb; 386():123-130. PubMed ID: 27845158
[TBL] [Abstract][Full Text] [Related]
16. Companion diagnostics for the targeted therapy of gastric cancer.
Yoo C; Park YS
World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts.
Ji F; Liu X; Wu Y; Fang X; Huang G
Drug Des Devel Ther; 2015; 9():5697-704. PubMed ID: 26543351
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies in the treatment of gastric cancer.
Ngeow J; Tan IB; Choo SP
Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21: Mechanisms of Oncogenesis and its Application in Diagnosis and Prognosis of Gastric Cancer.
Karimi Kurdistani Z; Saberi S; Tsai KW; Mohammadi M
Arch Iran Med; 2015 Aug; 18(8):524-36. PubMed ID: 26265521
[TBL] [Abstract][Full Text] [Related]
20. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
Wang S; Yuan L
Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
